Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Proqr Therapeutics (PRQR)

3.4 0.05 (1.49%)

02-23 14:42

Open:

3.4

Pre. Close:

3.35

High:

3.4

Low:

3.375

Volume:

8,255

Market Cap:

108M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

3.505 - 3.523

3.523 - 3.537

Low:

3.31 - 3.328

3.328 - 3.343

Close:

3.323 - 3.352

3.352 - 3.375

Technical analysis  (as of: 2018-02-23 1:43:55 PM)

Overall:

      

Stoxline posted a NEUTRAL today, upgraded from lower rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 4.15     One year: 4.84

Support:

Support1: 3.09    Support2: 2.80

Resistance:

Resistance1: 3.55    Resistance2: 4.15

Pivot:

3.23

Moving Averages:

MA(5): 3.44     MA(20): 3.21

MA(100): 3.45     MA(250): 4.38

MACD:

MACD(12,26): 0.08     Signal(12,26,9): 0.04

%K %D:

%K(14,3): 82.20     %D(3): 86.91

RSI:

RSI(14): 59.25

52-Week:

High: 6.9  Low: 2.75  Change(%): -15.0

Average Vol(K):

3-Month: 9502  10-Days 5985

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
PRQR has closed below upper band by 27.8%. Bollinger Bands are 12.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tue, 12 Sep 2017 10:52:30 GMT
ProQR spins out Amylon Therapeutics as a privately-held company focused on ...

Thu, 09 Jun 2016 14:21:48 GMT
ProQR Therapeutics NV

Mon, 27 Mar 2017 10:52:30 GMT
ProQR Appoints David M. Rodman, MD as Chief Development Strategy Officer

Mon, 28 Aug 2017 10:52:30 GMT
ProQR Strengthens its Scientific Advisory Board with the Appointment of Dr ...

Thu, 15 Jun 2017 11:03:45 GMT
ProQR R&D day Highlights Progress on Pipeline and Introduces Axiomer®, a novel ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

25.46

Shares Float (M)

25.46

% Held by Insiders

% Held by Institutions

59.90

Shares Short (K)

41

Shares Short Prior Month (K)

121

Stock Financials

EPS

-1.900

EPS Est. Current Year

-2.110

EPS Est. Next Year

-1.740

EPS Est. Next Quarter

-0.520

Forward EPS

-1.577

Book Value (p.s.)

2.180

PEG Ratio

Profit Margin

Operating Margin

-4492.71

Return on Assets (ttm)

-69.5

Return on Equity (ttm)

-87.4

Qtrly Rev. Growth

-66.7

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-1.653

Qtrly Earnings Growth

Operating Cash Flow (M)

-41.84

Levered Free Cash Flow (M)

-25.37

atoplab.com

Valuation

P/E

-1.79

P/E Growth Ratio

0.01

P/BV

1.56

P/S

2166161408.00

P/CF

-2.07

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.